By Bahar YukselUnveiling the Immunological Puzzle: Modulation of Biomarkers in Endometriosis by Progestin Therapy
By Bahar Yuksel
The study by Daniela Roxana Matasariu et al., aimed to investigate the effects of progestin treatment on the expression of biomarkers in endometriosis, specifically focusing on osteopontin and CD44; and their potential role in the pathogenesis of endometriosis. The researchers…
Key Points Lay Summary
By Dr. Youngran ParkOsteopontin and Endometriosis
By Dr. Youngran Park
Although characterized as a benign disease, some properties of endometriosis mimic malignant tissues such as proliferation, cell invasion, and metastasis. Osteopontin, also called secreted phosphoprotein 1, is one of the important molecular targets in cancer progression and metastasis. Osteopontin has been…
Key Points Lay Summary
Plausible biomarkers for noninvasive endometriosis diagnosis
By Dr. Youngran Park
Endometriosis is an estrogen-dependent benign gynecological disease characterizing ectopic deposition of endometrial tissue outside of the uterine cavity. It affects about 10% of reproductive-aged women and causes enormous negative impacts on the quality of lives. However, we do not have…
Key Points Lay Summary